LOSI, Lorena
 Distribuzione geografica
Continente #
NA - Nord America 11.544
EU - Europa 10.361
AS - Asia 1.600
SA - Sud America 54
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 23.571
Nazione #
US - Stati Uniti d'America 11.468
IT - Italia 4.852
GB - Regno Unito 2.849
SE - Svezia 742
CN - Cina 568
DE - Germania 561
SG - Singapore 346
UA - Ucraina 327
HK - Hong Kong 279
FI - Finlandia 245
FR - Francia 237
TR - Turchia 217
BG - Bulgaria 143
IN - India 62
RU - Federazione Russa 54
CA - Canada 48
AL - Albania 47
BE - Belgio 47
ID - Indonesia 39
RO - Romania 35
NL - Olanda 28
IE - Irlanda 26
PL - Polonia 26
LT - Lituania 25
VN - Vietnam 25
ES - Italia 23
MY - Malesia 22
BR - Brasile 19
CH - Svizzera 19
MX - Messico 19
AR - Argentina 17
CZ - Repubblica Ceca 15
LV - Lettonia 14
PT - Portogallo 10
IL - Israele 9
IR - Iran 8
JP - Giappone 8
CL - Cile 7
DK - Danimarca 6
GR - Grecia 6
KR - Corea 6
AU - Australia 5
BZ - Belize 5
NO - Norvegia 5
PE - Perù 5
AT - Austria 3
EU - Europa 3
GT - Guatemala 3
SI - Slovenia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
EC - Ecuador 2
HU - Ungheria 2
MD - Moldavia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PY - Paraguay 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
EE - Estonia 1
HN - Honduras 1
LK - Sri Lanka 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TW - Taiwan 1
Totale 23.571
Città #
Southend 2.496
Fairfield 1.665
Woodbridge 1.129
Chandler 940
Ashburn 878
Houston 800
Jacksonville 676
Seattle 651
Cambridge 591
Wilmington 577
Dearborn 574
Ann Arbor 532
Nyköping 485
Rome 385
Modena 303
Hong Kong 275
Milan 252
Singapore 205
Beijing 184
San Diego 175
Princeton 157
Izmir 143
Sofia 135
Helsinki 131
Eugene 130
New York 112
Naples 92
Bologna 86
Bari 83
Frankfurt am Main 80
Bremen 77
Turin 74
Palermo 68
Florence 61
Des Moines 59
London 57
Shanghai 55
Cagliari 54
Redwood City 51
Fremont 47
Parma 47
Boardman 46
Verona 45
Jakarta 39
Reggio Emilia 36
Brussels 35
Padova 35
Tirana 35
Catania 33
Falls Church 33
Perugia 32
Pescara 31
Napoli 28
Genoa 27
Nanjing 26
Dublin 24
Trieste 23
Dong Ket 22
Hefei 22
Toronto 22
Ottawa 21
Brescia 20
Hounslow 19
Kilburn 19
Chicago 18
Kunming 18
Phoenix 18
San Giuliano Milanese 18
Siena 17
Grafing 16
Guangzhou 16
Monza 16
Piacenza 16
Los Angeles 15
Pisa 15
Taranto 15
Chieti 14
Chiswick 14
Venice 14
Norwalk 13
Paris 13
Pavia 13
Salerno 13
Munich 12
Buenos Aires 11
Ferrara 11
Madrid 11
San Mateo 11
Udine 11
Augusta 10
Bagheria 10
Brno 10
Dallas 10
Indiana 10
Reggio Calabria 10
Romainville 10
Saint Petersburg 10
Trento 10
Warsaw 10
Imola 9
Totale 16.713
Nome #
Robbins e Cotran Atlante di Anatomia Patologica 4.157
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells 307
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 294
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. 283
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 251
Repurposing of drugs targeting yap-tead functions 249
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 231
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 229
Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes. 225
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines 218
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 216
Exome sequencing and bioinformatic approaches reveals rare sequence variants involved in cell signalling and elastic fibre homeostasis: new evidence in the development of ectopic calcification 212
Promoter Methylation and Down-regulated Expression of the TBX15 Gene in Ovarian Carcinoma 206
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 200
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 200
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 196
Loss of expression of μ-protocadherin and protocadherin-24 in sporadic and hereditary nonpolyposis colorectal cancers 193
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 193
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 193
Desmoplastic melanoma: a challenge for the oncologist 192
Aetiology of colorectal cancer and relevance of monogenic inheritance. 191
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 189
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 188
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 188
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 186
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 185
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 184
Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers 184
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 183
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations. 180
Microsatellite instability and colorectal cancer prognosis. 178
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 176
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 176
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 174
Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis 172
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 171
Aberrant crypt foci in patients with colorectal cancer 170
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 170
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 167
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 164
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 164
High Expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells 163
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells 163
Stability of K-ras mutations throughout the natural history of human colorectal cancer. 163
Assessment of K-ras, Smad4 and p53 gene alterations in colorectal metastases and their role in the metastatic process 162
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 162
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 161
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 161
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression 159
Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. 158
K-ras and p53 mutations in human colorectal aberrant crypt foci 155
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 155
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 155
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 155
Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases 155
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 155
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 154
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 154
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 151
DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM) 149
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 149
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 148
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 147
Deep learning techniques for detecting preneoplastic and neoplastic lesions in human colorectal histological images 146
Pigment epithelial-derived factor: a new player in dermal elastic fibre calcification? 145
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 144
Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions RID B-2583-2012 143
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 142
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 140
Prognostic value of "Dworak" tumor regression grade (TRG) after pre-operative chemo-radiotherapy in rectal cancer (RC) 140
Expression of p53 protein in prostate cancers of different histologic types. 139
Microsatellite instability in multiple colorectal tumors 138
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 137
Survival for colon and rectal cancer in a population-based cancer registry 136
Prognostic significance of K-ras mutations in colorectal carcinoma. 135
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer 135
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer 134
Myxoid metastases of melanoma: report of three cases and review of the literature 133
Histology of aberrant crypt foci in the human colon 131
Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals 130
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 129
Paneth and argyrophil cells in prostatic carcinoma. 125
Colorectal carcinoma in different age groups: A population based investigation 125
Ventricular Arrhythmias After Intramyocardial Administration of Mesenchymal Bone Marrow Stem Cells in Acute Myocardial Infarction: An Animal Model 125
MELANOSIS (PIGMENTED MELANOCYTOSIS) OF THE PROSTATE GLAND. 125
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 124
Preoperative Therapy for Lower Rectal Cancer and Modifications in Distance From Anal Sphincter 122
Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in Northern Italy. Colorectal Cancer Study Group. 121
Biological characterization of mucinous carcinoma of the colon and rectum 115
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 115
Cell kinetics evaluation of colorectal tumours after in vivo administration of bromodeoxyuridine 115
CDX-2 homeobox gene and MUC2 expression identifies true mucinous (so-called colloid) carcinoma of the lung and justifies its indolent outcome 114
Pathological findings in perinatal autopsies 111
Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells 108
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 107
Low rectal cancer and distance from anal sphincter before and after preoperative therapy 106
Cardiac arrhythmias after intramyocardial administration of mesenchymal bone marrow stem cells in acute myocardial infarction 105
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 104
Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer 103
Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacantomas: role of clinical features, microsatellite instability and immunohistochemistry 102
Totale 20.268
Categoria #
all - tutte 103.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.082


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.067 0 0 138 261 537 649 716 507 555 197 290 217
2020/20213.860 416 140 296 365 397 319 324 474 231 432 243 223
2021/20223.358 134 361 305 241 124 176 224 201 359 225 649 359
2022/20233.584 377 366 236 330 371 456 148 356 401 119 215 209
2023/20243.619 187 202 247 363 571 310 287 376 152 288 262 374
2024/2025583 314 144 125 0 0 0 0 0 0 0 0 0
Totale 23.786